Angel’s Trumpet

OTHER NAME(S): Devil's Trumpet, Floripondio, Stramoine Inoffensive, Stramoine Parfumée, Trompeta de Ángel, Trompette des Ange, Trompette du Jugement, Brugmansia arborea, Brugmansia suaveolens, Brugmansia species, Datura arborea, Datura suaveolens, Datura sauveolens, Trompeta De Ángel, Trompette Des Anges

Overview

Angel's trumpet is a plant. The leaves and flowers are used to make medicine.

Despite serious safety concerns, people use angel's trumpet as a recreational drug to induce hallucinations and euphoria. It is also used for asthma and other conditions, but there is no good scientific evidence to support these uses.

Angel's trumpet contains chemicals that can cause euphoria and hallucinations.

Angel's trumpet contains chemicals that can cause euphoria and hallucinations.

References
  1. McEvoy GK, ed. AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists, 1998.
  2. Burnham TH, ed. Drug Facts and Comparisons, Updated Monthly. Facts and Comparisons, St. Louis, MO.
  3. Anon. Plant Poisonings - New Jersey. MMWR Morb Mortal Wkly Rep 1981;30:65-7.
  4. Urich RW, Bowerman DL, Levisky JA, Pflug JL. Datura stramonium: a fatal poisoning. J Forensic Sci 1982;27:948-54.
  5. McHenry LE, Hall RC. Angel's trumpet. Lethal and psychogenic aspects. J Fla Med Assoc 1978;65:192-6.
  6. Hall RC, Popkin MK, Mchenry LE. Angel's Trumpet psychosis: a central nervous system anticholinergic syndrome. Am J Psychiatry 1977;134:312-4.
  7. Greene GS, Patterson SG, Warner E. Ingestion of angel's trumpet: an increasingly common source of toxicity. South Med J 1996;89:365-9.
  8. Francis PD, Clarke CF. Angel trumpet lily poisoning in five adolescents: clinical findings and management. J Paediatr Child Health 1999;35:93-5.
  9. Gopel, C., Laufer, C., and Marcus, A. Three cases of angel's trumpet tea-induced psychosis in adolescent substance abusers. Nord.J.Psychiatry 2002;56(1):49-52.
  10. Havelius, U. and Asman, P. Accidental mydriasis from exposure to Angel's trumpet (Datura suaveolens). Acta Ophthalmol.Scand. 2002;80(3):332-335.
  11. Mobus, U., Demmler, G., and Schulz, K. [Accidental drowning due to tropane alkaloid abuse]. Arch Kriminol. 2002;210(1-2):16-21.
  12. Isbister, G. K., Oakley, P., Dawson, A. H., and Whyte, I. M. Presumed Angel's trumpet (Brugmansia) poisoning: clinical effects and epidemiology. Emerg.Med.(Fremantle.) 2003;15(4):376-382.
  13. Marneros, A., Gutmann, P., and Uhlmann, F. Self-amputation of penis and tongue after use of Angel's Trumpet. Eur.Arch.Psychiatry Clin.Neurosci. 2006;256(7):458-459.
  14. Smith, E. A., Meloan, C. E., Pickell, J. A., and Oehme, F. W. Scopolamine poisoning from homemade 'moon flower' wine. J Anal.Toxicol 1991;15(4):216-219.
  15. Hayman, J. Datura poisoning--the Angel's Trumpet. Pathology 1985;17(3):465-466.
  16. McHenry, L. E. and Hall, R. C. Angel's trumpet. Lethal and psychogenic aspects. J.Fla.Med.Assoc. 1978;65(3):192-196.
  17. Hassell, L. H. and MacMillan, M. W. Acute anticholinergic syndrome following ingestion of Angel's Trumpet tea. Hawaii Med.J. 1995;54(7):669-670.
  18. Isbister GK, Oakley P, Dawson AH, Whyte IM. Presumed Angel's trumpet (Brugmansia) poisoning: clinical effects and epidemiology. Emerg Med (Fremantle). 2003;15(4):376-82.
  19. Zhang HL, Wang XF. Angel's trumpet-associated polyneuropathy-is it Guillain-Barré syndrome? Pediatr Neurol. 2011 Jul;45(1):63; author reply 63-4.
  20. Sevketoglu E, Tatli B, Tugcu B, Demirelli Y, Hatipoglu S. An unusual cause of fulminant Guillain-Barré syndrome: angel's trumpet. Pediatr Neurol. 2010;43(5):368-70.
  21. Serin HM, Ozen B, Yilmaz S. A rare cause of acute anisocoria in a child: The angel's trumpet plant. J Pediatr Ophthalmol Strabismus. 2018;55:e33-e35.
  22. Kim HG, Jang D, Jung YS, et al. Anti-inflammatory effect of flavonoids from Brugmansia arborea L. flowers. J Microbiol Biotechnol. 2020;30(2):163-171.
  23. Colosimo E, Clodomiro A, Pirritano D, et al. Ischemic stroke and provoked seizure as a manifestation of Brugmansia suaveolens (angel's trumpet) acute intoxication: a detailed clinical, electroencephalogram, and magnetic resonance imaging description and 5-month follow-up. Clin Neuropharmacol. 2021;44(6):231-234.